AIDX
20/20 Biolabs, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.24
+3.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.02x
- Price / sales
- 1.59x
- Price / cash flow
- -1.16x
Enterprise value
- Enterprise value
- $799.8K
- EV / sales
- 0.39x
- EV / EBITDA
- -0.17x
- EV / EBIT
- -0.18x
- Market cap
- $3.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026